rs142157418

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_033409.4(SLC52A3):​c.395G>A​(p.Arg132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000195 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R132W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )

Consequence

SLC52A3
NM_033409.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: -0.0150

Publications

2 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038506985).
BP6
Variant 20-765380-C-T is Benign according to our data. Variant chr20-765380-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476610.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00021 (32/152202) while in subpopulation NFE AF = 0.000412 (28/68010). AF 95% confidence interval is 0.000293. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033409.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
NM_033409.4
MANE Select
c.395G>Ap.Arg132Gln
missense
Exon 2 of 5NP_212134.3
SLC52A3
NM_001370085.1
c.395G>Ap.Arg132Gln
missense
Exon 3 of 6NP_001357014.1Q9NQ40-1
SLC52A3
NM_001370086.1
c.395G>Ap.Arg132Gln
missense
Exon 3 of 6NP_001357015.1Q9NQ40-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
ENST00000645534.1
MANE Select
c.395G>Ap.Arg132Gln
missense
Exon 2 of 5ENSP00000494193.1Q9NQ40-1
SLC52A3
ENST00000217254.11
TSL:5
c.395G>Ap.Arg132Gln
missense
Exon 3 of 6ENSP00000217254.7Q9NQ40-1
SLC52A3
ENST00000488495.3
TSL:3
c.395G>Ap.Arg132Gln
missense
Exon 2 of 5ENSP00000494009.1Q9NQ40-1

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152084
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000139
AC:
35
AN:
251230
AF XY:
0.000140
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000299
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000194
AC:
283
AN:
1461860
Hom.:
0
Cov.:
32
AF XY:
0.000193
AC XY:
140
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000250
AC:
278
AN:
1112004
Other (OTH)
AF:
0.0000662
AC:
4
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41548
American (AMR)
AF:
0.00
AC:
0
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000386
Hom.:
0
Bravo
AF:
0.000204
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000115
AC:
14
EpiCase
AF:
0.000491
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Brown-Vialetto-van Laere syndrome 1 (1)
-
1
-
Inborn genetic diseases (1)
-
1
-
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0087
T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.77
T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.039
T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
0.88
L
PhyloP100
-0.015
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.10
Sift
Benign
0.39
T
Sift4G
Benign
0.31
T
Polyphen
0.14
B
Vest4
0.069
MVP
0.65
MPC
0.36
ClinPred
0.051
T
GERP RS
2.5
PromoterAI
-0.0089
Neutral
Varity_R
0.033
gMVP
0.35
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142157418; hg19: chr20-746024; COSMIC: COSV105094366; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.